GlassScriptPhysician profile
Claire Thompson
NPI 1366201162
$1,023.91
in general payments reported to CMS, 2019-2025
19 companies · $727 in 2025
The $727 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $297 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $256.80 | 2025 | Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $120.60 | 2025 | Dupixent |
| Organon LLC | $96.37 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $85.42 | 2025 | Neffy |
| Abbvie INC. | $76.38 | 2024-2025 | |
| Exact Sciences Corporation | $46.44 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $46.28 | 2024-2025 | |
| Amgen INC. | $35.30 | 2024-2025 | Evenity, Prolia, Prolia |
| Lilly USA, LLC | $34.62 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $31.05 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $28.29 | 2025 | |
| Glaxosmithkline, LLC. | $24.49 | 2025 | Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $24.20 | 2025 | Abilify Asimtufii, Abilify Maintena |
| Dexcom, INC. | $22.42 | 2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $22.32 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $22.32 | 2025 | Veozah |
| Philips North America LLC | $18.66 | 2024 | (Ck7) Extended Holter |
| Phathom Pharmaceuticals, INC. | $18.61 | 2024 | Voquezna |
| Shield Therapeutics INC | $13.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.